In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.

Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

The Concerto™ System introduces a first-of-its-kind multiplexed, multi-omic digital detection platform, enabling real-time, high-plex quantification of DNA, RNA and protein biomarkers from a single ...

Bin Wu, associate professor in the department of Biophysics and Biophysical Chemistry at the School of Medicine, visited ...

An international collaboration has published groundbreaking research, shedding light on the most significant increase in complexity in the history of life's evolution on Earth: the origin of the ...

Proteins form the structural and functional backbone of the cell, and any perturbation in their synthesis can disrupt normal ...

The process of translation by ribosomes, which functions as a factory of protein synthesis, may be impeded by ‘ribosome ...

Researchers from Eli Lilly & Co. reported preclinical data on LY-3954068, a MAPT small-interference RNA (siRNA) strategy in AD models. The therapy is designed to reduce tau protein synthesis by ...

More insight into the process could improve crop productivity WEST LAFAYETTE, Ind. — Purdue University scientists have discovered a key mechanism that regulates how plants develop chloroplasts, ...

A new study identifies a blood-based biomarker that detects pre-symptomatic Parkinson’s disease by measuring the ratio of ...

Notably, they discovered genes associated with protein translation to influence pluripotency substantially. In particular, they focused on EIF3D, which dramatically reduced cells with primed ...